Anaplastic Oligodendroglioma (AO) Completed Phase 1 Trials for AZD-8055 (DB12774)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01316809
AZD8055 for Adults With Recurrent GliomasTreatment